AN2 Therapeutics Inc

ANTXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$5.57

Today

-2.5%

YTD

+414.4%

About

AN2 Therapeutics Inc is a global name in the pharmaceutical sector. The company focuses on the discovery, development and commercialisation of new therapies for patients with severe lung diseases. It operates on a global scale, using a strategic approach to innovation and research. Part of the pharmaceutical industry, AN2 Therapeutics Inc works to treat rare, chronic and serious infectious diseases. It provides novel therapies, focusing on patient care and advancing medicinal knowledge. The company also has a strategic partnership with Brii Biosciences. Monitor the ANTX share price by adding it to your eToro watchlist.

Price chart

Closing price history for ANTX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-5.32

P/S (TTM)0.00

P/B (TTM)2.73

Market cap$215.47M

Cap tierMicro-cap

Industry avg P/E-7.37

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-50.12%

ROA-46.06%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$1.07

Free cash flow$-30.68M

Total debt$0.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.73

Employees21

Next earnings14 Aug '25

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.